Myelodysplastic Syndrome Research

Getting treated for myelodysplasia at City of Hope means you are steps away from labs where new treatments are being developed every day. That proximity means you benefit from something unique — bench to bedside treatment. "Bench to bedside" means innovative research we are conducting in our labs is moved quickly to the bedside to treat our patients.

We are at the forefront of new therapies, and have the technology to identify new potential targets for new drugs. And we offer access to a wide variety of clinical trials not always available to the general public. Our latest research is focused on eliminating graft-versus-host disease in transplant patients, and reducing the risk of MDS developing into leukemia.

Browse through some of our clinical trials and research projects.